Zacks.com users have recently been watching Bristol Myers (BMY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) announced in Q4 CY2024, with sales up 7.5% year on year to $12.34 ...

HIDDEN under the shadow of an Ikea superstore, this so-called ‘caravan city’ reveals the stark reality of life for those without a home to even furnish. Freezing in below-zero ...

Replimune's innovative cancer therapies, strong cash reserves, and FDA support position it to disrupt oncology markets. Click ...

S&P 500 futures pared an early gain fueled by Treasury Secretary Scott Bessent’s comment that the Trump administration is ...

Yahoo Finance Anchor Josh Lipton recaps the top stories on Wall Street as part of today's Market Minute ... results and issued a strong outlook. Bristol-Myers Squibb (BMY) shares are under ...

Bristol Myers Squibb said it will slash $2 billion in costs by the end of 2027, expanding its ongoing cost-savings effort to chart a path toward long-term growth. The company also issued full ...

It is the last day of the Bristol Light Festival 2025, an event which has brought crowds of people to the city centre to see the after-dark attractions. Talking of after dark, a special show at ...

The drugmaker Bristol Myers Squibb has been a standout among its big pharma peers over the past six months, scoring a ...

37,249 people played the daily Crossword recently. Can you solve it faster than others?37,249 people played the daily Crossword recently. Can you solve it faster than others? Warren Buffett Just ...

According to the survey commissioned by Skipton Building Society found a quarter picture eco-friendly ocean-based communities and homes powered by green energy. Many also visualised smart clothing ...